Education
About Us
Working with TipRanks
Follow Us
Heartseed, Inc. (JP:219A)
:219A
219A Stock Chart & Stats
¥1830.00
-¥95.00(-2.73%)
At close: 4:00 PM EST
¥1830.00
-¥95.00(-2.73%)
Day’s Range― - ―
52-Week Range¥1,207.00 - ¥4,385.00
Previous CloseN/A
Volume1.41M
Average Volume (3M)2.40M
Market Cap
¥39.53B
Enterprise Value¥76.91B
Total Cash (Recent Filing)¥6.92B
Total Debt (Recent Filing)¥2.04M
Price to Earnings (P/E)75.1
Beta1.25
Next Earnings
Dec 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-20.35
Shares Outstanding22,811,000
10 Day Avg. Volume612,330
30 Day Avg. Volume2,400,759
Financial Highlights & Ratios
PEG Ratio0.83
Price to Book (P/B)4.62
Price to Sales (P/S)35.06
P/FCF Ratio-21.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Heartseed, Inc. News
219A FAQ
What was Heartseed, Inc.’s price range in the past 12 months?
Heartseed, Inc. lowest stock price was ¥1207.00 and its highest was ¥4385.00 in the past 12 months.
What is Heartseed, Inc.’s market cap?
Heartseed, Inc.’s market cap is ¥39.53B.
When is Heartseed, Inc.’s upcoming earnings report date?
Heartseed, Inc.’s upcoming earnings report date is Dec 11, 2025 which is in 36 days.
How were Heartseed, Inc.’s earnings last quarter?
Heartseed, Inc. released its earnings results on Sep 11, 2025. The company reported -¥20.351 earnings per share for the quarter, missing the consensus estimate of N/A by -¥20.351.
Is Heartseed, Inc. overvalued?
According to Wall Street analysts Heartseed, Inc.’s price is currently Overvalued.
Does Heartseed, Inc. pay dividends?
Heartseed, Inc. does not currently pay dividends.
What is Heartseed, Inc.’s EPS estimate?
Heartseed, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Heartseed, Inc. have?
Heartseed, Inc. has 22,811,000 shares outstanding.
What happened to Heartseed, Inc.’s price movement after its last earnings report?
Heartseed, Inc. reported an EPS of -¥20.351 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.583%.
Which hedge fund is a major shareholder of Heartseed, Inc.?
Currently, no hedge funds are holding shares in JP:219A
Company Description
Heartseed, Inc.
Heartseed, Inc. is a biotechnology company focused on developing innovative therapies for cardiovascular diseases. With a commitment to transforming the treatment landscape, Heartseed specializes in regenerative medicine and stem cell technology, aiming to restore heart function and improve patient outcomes. The company operates within the healthcare sector, leveraging cutting-edge research and clinical trials to bring its core products, including advanced cellular therapies and drug candidates, to market.
Technical Analysis
JCR Pharmaceuticals Co., Ltd.
―
Mizuho Medy Co., Ltd.
―
StemRIM Inc.
―
Cuorips Inc.
―
Japan Tissue Engineering Co., Ltd.
―